Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | EVP, Gen. Counsel & Secretary | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 119,024 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 48,076 · Balance 119,024 F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting.
F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2017 Filed Mar 31, 2017 16:52 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 6,000 | $28.24 | $169,440.00 |
DisclosureSEC source: 0001209191-17-023887 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-17-017015 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,219 Underlying: Class A Common Stock · 6,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,000 | $50.00 | $300,000.00 |
DisclosureSEC source: 0001209191-17-017015 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,935 F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 6,000 | $28.24 | $169,440.00 |
DisclosureSEC source: 0001209191-17-017015 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 17:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-17-006768 · doc4.xml · derivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,219 Underlying: Class A Common Stock · 10,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 17:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 10,000 | $47.59 | $475,859.00 |
DisclosureSEC source: 0001209191-17-006768 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,935 F1 · price: This transaction was executed in multiple trades at prices ranging from $47.28 to $47.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 17:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 10,000 | $28.24 | $282,400.00 |
DisclosureSEC source: 0001209191-17-006768 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 17:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,409 | $47.67 | $114,840.16 |
DisclosureSEC source: 0001209191-17-006768 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,935 F1 · price: This transaction was executed in multiple trades at prices ranging from $47.28 to $47.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 22, 2016 Filed Dec 22, 2016 19:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,119 | $46.07 | $51,547.74 |
DisclosureSEC source: 0001209191-16-156602 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,344 F3 · price: This transaction was executed in multiple trades at prices ranging from $45.97 to $46.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 31,861 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 19:31 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,879 | $46.30 | $86,997.70 |
DisclosureSEC source: 0001209191-16-156602 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,463 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 31,861 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2016 Filed Dec 19, 2016 19:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,082 | $45.96 | $49,726.99 |
DisclosureSEC source: 0001209191-16-156015 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,342 F7 · price: The shares were sold in multiple transactions at prices ranging from $45.77 to $46.23, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · balance_after: Shares held following the reported transactions include 35,461 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,271 | $45.71 | $103,799.23 |
DisclosureSEC source: 0001209191-16-156015 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,424 F6 · price: The shares were sold in multiple transactions at prices ranging from $45.50 to $45.93, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · balance_after: Shares held following the reported transactions include 35,461 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,817 | $45.86 | $83,327.62 |
DisclosureSEC source: 0001209191-16-156015 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,695 F3 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 35,461 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 52,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-16-156015 · doc4.xml · derivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Class A Common Stock · 52,000 shares Expires 2026-12-15 F9 · derivative.exercise_date: This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Stock Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-16-156015 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Class A Common Stock · 26,000 shares Expires 2023-12-15 F8 · derivative.exercise_date: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2016 and ending December 15, 2019. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,632 | $45.50 | $119,756.00 |
DisclosureSEC source: 0001209191-16-156015 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,512 F3 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F4 · balance_after: Shares held following the reported transactions include 38,943 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156015 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,144 F1 · acquired: Award represents a total of 13,000 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2016. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 45,070 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 01, 2016 Filed Dec 1, 2016 17:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftClass A Common Stock | 97 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-152737 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,144 F1 · kind: Gifts to charitable and/or non-profit organizations. F2 · balance_after: Shares held following the reported transactions include 32,070 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 17:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftClass A Common Stock | 98 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-152737 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,241 F1 · kind: Gifts to charitable and/or non-profit organizations. F2 · balance_after: Shares held following the reported transactions include 32,070 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.